$HCM Balance Sheet | Understand Stock

$HCM

$13.80 -$0.47 (3.29%) Close

$HCM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016
Assets
Current assets
Cash and cash equivalents
Short-term investments
Accounts receivable
Related parties
Total accounts receivable
Accounts receivable-related parties
Other receivables, prepayments and deposits
Amounts due from related parties
Inventories
Deferred tax assets
Total current assets

Property, plant and equipment
Right-of-use assets
Leasehold land
Deferred tax assets
Investment in equity investees
Amount due from a related party
Deferred issuance cost
Investment in equity security
Amounts due from related parties
Goodwill
Long-term prepayment
Other intangible asset
Other non-current assets
Total assets

Liabilities and shareholders' equity
Current liabilities
Accounts payable
Accounts payable—related parties
Other payables, accruals and advance receipts
Related parties
Total other payables, accruals and advance receipts
Deferred tax liabilities
Other payables and accruals
Related parties
Total other payables and accruals
Short-term bank borrowings
Deferred revenue
Amounts due to a related party
Income tax payable
Other current liabilities
Lease liabilities
Total current liabilities

Lease liabilities, non-current portion
Deferred tax liabilities
Long-term bank borrowings
Deferred revenue, non-current portion
Other deferred income
Other non-current liabilities
Third parties
Related parties
Total other non-current liabilities
Total liabilities
Company's shareholders' equity
Ordinary shares; $0.10 par value; 1,500,000,000 shares authorized; 872,327,620 and 871,601,095 shares issued at December 31, 2025 and 2024 respectively
Additional paid-in capital
Accumulated losses
Accumulated other comprehensive loss
Total Company's shareholders' equity
Non-controlling interests
Total shareholders' equity
Total liabilities and shareholders' equity

Comments